Navigating EGFR-Mutant Advanced NSCLC Cancer Treatment: A Patient's Journey

EP: 1.Overview of EGFR-Mutant Advanced NSCLC

EP: 2.EGFR-Mutant NSCLC Diagnosis: Insights from Patients and Clinicians

EP: 3.Coordinating Care for Patients with Advanced EGFR-Mutant NSCLC: A Multidisciplinary Approach

EP: 4.Multidisciplinary Care of EGFR-Mutant Advanced NSCLC: A Patient Perspective

EP: 5.Tailoring Patient Education and Resources in EGFR-Mutant Advanced NSCLC

Now Viewing

EP: 6.Navigating EGFR-Mutant Advanced NSCLC Cancer Treatment: A Patient's Journey

EP: 7.Shared Decision Making in EGFR-Mutant Advanced NSCLC

EP: 8.Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC

EP: 9.Intricacies of EGFR-Mutated NSCLC Care From the Patient Perspective

EP: 10.Patient Perspectives on Managing Side Effects from Amivantamab

EP: 11.Comprehensive Supportive Care for EGFR-Mutant Advanced NSCLC

EP: 12.Patient Perspective: Key Aspects of Supportive Care in the EGFR-Mutant Advanced NSCLC Journey

EP: 13.Future Perspectives in EGFR-Mutant Advanced NSCLC

Video content above is prompted by the following:

• Can you briefly walk us through your treatment journey for advanced EGFR-Mutant NSCLC?
• What specific treatments did you receive and how did you respond?
• Please provide a high-level overview of the systemic therapies that you consider for advanced EGFR-Mutant NSCLC.
• What is the role of amivantamab in treating advanced EGFR-Mutant NSCLC?
• How does your management approach differ based on patient and disease characteristics?
• How do available data guide your treatment decisions?